Jamp-doxazosin 4 Mg: The Uniformity Of Dosage Unit May Be Out Of Specification In The Affected Lot.
JAMP-Doxazosin 4 mg tablets are being recalled in Canada because some tablets in the affected lot may contain incorrect amounts of the active ingredient. This is a Class I recall, meaning there is a potential health risk. The recall affects all Canadian consumers who have this medication.
- Product
- JAMP-Doxazosin 4 mg
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-06-25
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/296f4000-4616-4d38-81fa-68475bc79c35